Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
37.48
-3.09 (-7.62%)
At close: Oct 10, 2025, 4:00 PM EDT
37.95
+0.47 (1.25%)
After-hours: Oct 10, 2025, 7:58 PM EDT

Harrow Revenue

Harrow had revenue of $63.74M in the quarter ending June 30, 2025, with 30.25% growth. This brings the company's revenue in the last twelve months to $227.66M, up 47.69% year-over-year. In the year 2024, Harrow had annual revenue of $199.61M with 53.32% growth.

Revenue (ttm)
$227.66M
Revenue Growth
+47.69%
P/S Ratio
5.93
Revenue / Employee
$595,971
Employees
382
Market Cap
1.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024199.61M69.42M53.32%
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 202048.87M-2.29M-4.48%
Dec 31, 201951.17M9.79M23.67%
Dec 31, 201841.37M14.60M54.52%
Dec 31, 201726.77M6.83M34.26%
Dec 31, 201619.94M10.23M105.25%
Dec 31, 20159.72M8.06M485.30%
Dec 31, 20141.66M-8.34M-83.40%
Dec 31, 201310.00M--
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings